Turkish Biotechnology Company ENBIOSIS Is Designing the Future of Food with Artificial Intelligence
Published
Turkish biotechnology company ENBIOSIS is bringing a new perspective to food production. The company designs foods using the discipline of drug development. In other words, when determining the content of a product, it uses scientific testing and controlled development processes.
The company's most important area of work is its AI-supported formulation platform. Formulation is the process of determining which substances will be contained in a product and in what proportions. Artificial intelligence can analyze large amounts of information in a short time and offer suggestions on how these mixtures can be prepared. This method aims to make development work faster and more planned compared to traditional trial-and-error processes.
The food sector faces issues such as changing dietary habits around the world, increasing demand for healthy products, and the more efficient use of natural resources. For this reason, fields such as biotechnology and artificial intelligence are gaining increasing importance in the food sector. ENBIOSIS's approach stands out as a concrete example of this development in Türkiye.
In conclusion, ENBIOSIS offers a new working model by bringing together artificial intelligence and drug development methods in the field of food. How the company's work will shape the future of food will become clearer in the coming period.
Sources: Fortune Turkey
More Turkey news
- Romelu Lukaku will not play in Türkiye-Belgium match
- Romelu Lukaku will not play in Belgium's match against Turkey
- ASELSAN to build five-factory complex in Malatya, Turkey
- Pasifik Teknoloji to Supply Pakistan 100,000 Merkut Drones
- MSCI removes Sabancı Holding and Astor Enerji from main index
- MSCI removes 18 Turkish stocks from Türkiye indexes, adds 2
- MSCI removes 18 Turkish stocks and adds two to index
- The Target of the National Women's Basketball Team Is the European Championship